Latest Insider Transactions at Acelyrin, Inc. (SLRN)
This section provides a real-time view of insider transactions for Acelyrin, Inc. (SLRN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ACELYRIN, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ACELYRIN, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 09
2023
|
Shao Lee Lin Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
1,107,213
+50.0%
|
-
|
|
May 09
2023
|
Shao Lee Lin Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
1,107,213
-100.0%
|
-
|
|
May 09
2023
|
Shao Lee Lin Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
1,161,747
+50.0%
|
-
|
|
May 09
2023
|
Mardi Dier CFO and CBO |
BUY
Open market or private purchase
|
Indirect |
1,750
+50.0%
|
$31,500
$18.0 P/Share
|
|
May 09
2023
|
Mardi Dier CFO and CBO |
BUY
Open market or private purchase
|
Direct |
5,556
+50.0%
|
$100,008
$18.0 P/Share
|
|
May 09
2023
|
Paul Peloso Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
6,000
+50.0%
|
$108,000
$18.0 P/Share
|
|
May 09
2023
|
Ayur Maya Capital Management Company, LP Director |
BUY
Conversion of derivative security
|
Indirect |
9,334,735
+50.0%
|
-
|